{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:06:53Z","timestamp":1789056413070,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["FIS-2023-00171"],"award-info":[{"award-number":["FIS-2023-00171"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001279","name":"Great Ormond Street Hospital Children's Charity","doi-asserted-by":"publisher","award":["V4522"],"award-info":[{"award-number":["V4522"]}],"id":[{"id":"10.13039\/501100001279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001279","name":"Great Ormond Street Hospital Children's Charity","doi-asserted-by":"publisher","award":["VS0420"],"award-info":[{"award-number":["VS0420"]}],"id":[{"id":"10.13039\/501100001279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003784","name":"Great Ormond Street Hospital for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["217112\/Z\/19\/Z"],"award-info":[{"award-number":["217112\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omta.2026.201816","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:07:36Z","timestamp":1784736456000},"page":"201816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["In-depth characterization of stem cell potency and genotoxicity for clinical-scale ex vivo CRISPR-Cas9 gene editing"],"prefix":"10.1016","volume":"34","author":[{"given":"Asma","family":"Naseem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston","family":"Vetharoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Zinghirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Carusillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopkatha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Gomez-Castaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashim","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Thrasher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Santilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cesana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giandomenico","family":"Turchiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4735-2121","authenticated-orcid":false,"given":"Alessia","family":"Cavazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201816_bib1","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1038\/s41467-023-42036-5","article-title":"CRISPR-Cas9 engineering of the RAG2 locus via complete coding sequence replacement for therapeutic applications","volume":"14","author":"Allen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201816_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jaci.2024.03.003","article-title":"Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia","volume":"154","author":"Bahal","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.omta.2026.201816_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh8162","article-title":"Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency","volume":"16","author":"Castiello","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omta.2026.201816_bib4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 beta-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201816_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.omtm.2021.05.001","article-title":"Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency","volume":"22","author":"Fa\u00f1anas-Baquero","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201816_bib6","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1038\/s41467-020-17626-2","article-title":"Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome","volume":"11","author":"Rai","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201816_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/hum.2023.100","article-title":"CRISPR\/Cas9-Based Disease Modeling and Functional Correction of Interleukin 7 Receptor Alpha Severe Combined Immunodeficiency in T-Lymphocytes and Hematopoietic Stem Cells","volume":"35","author":"Rai","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201816_bib8","article-title":"A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells","volume":"5","author":"Della Volpe","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.omta.2026.201816_bib9","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.stem.2022.09.001","article-title":"Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells","volume":"29","author":"Ferrari","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omta.2026.201816_bib10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.stem.2024.04.005","article-title":"Impact of CRISPR\/HDR editing versus lentiviral transduction on long-term engraftment and clonal dynamics of HSPCs in rhesus macaques","volume":"31","author":"Lee","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omta.2026.201816_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.stem.2019.02.019","article-title":"Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response","volume":"24","author":"Schiroli","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omta.2026.201816_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41467-023-43413-w","article-title":"Transient inhibition of 53BP1 increases the frequency of targeted integration in human hematopoietic stem and progenitor cells","volume":"15","author":"Baik","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201816_bib13","article-title":"Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9\/AAV6-mediated gene editing in hematopoietic stem cells","volume":"6","author":"Conti","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.omta.2026.201816_bib14","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1182\/blood.2020008503","article-title":"Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem\/progenitor cells","volume":"137","author":"De Ravin","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201816_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.omtm.2023.02.014","article-title":"An improved medium formulation for efficient ex vivo gene editing, expansion and engraftment of hematopoietic stem and progenitor cells","volume":"29","author":"Rai","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201816_bib16","article-title":"Gene Editing and Genotoxicity: Targeting the Off-Targets","volume":"2","author":"Blattner","year":"2020","journal-title":"Front Genome"},{"key":"10.1016\/j.omta.2026.201816_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1186\/s12916-024-03690-8","article-title":"Synthesizing regulatory guidance for demonstrating preclinical efficacy and translating promising cell therapies to early phase clinical trials: a scoping review","volume":"22","author":"Jeffers","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.omta.2026.201816_bib18","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/s41592-023-02014-7","article-title":"Extending support for mouse data in the Molecular Signatures Database (MSigDB)","volume":"20","author":"Castanza","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omta.2026.201816_bib19","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/s41587-020-0551-y","article-title":"Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking","volume":"38","author":"Ferrari","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201816_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nbt.4021","article-title":"Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency","volume":"36","author":"Canny","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201816_bib21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1089\/hum.2023.114","article-title":"Multidimensional Response Surface Methodology for the Development of a Gene Editing Protocol for p67(phox)-Deficient Chronic Granulomatous Disease","volume":"35","author":"Whittaker","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201816_bib22","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.ymthe.2021.09.001","article-title":"Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells","volume":"29","author":"Lee","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201816_bib23","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.stem.2021.02.002","article-title":"Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq","volume":"28","author":"Turchiano","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omta.2026.201816_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature13619","article-title":"Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells","volume":"512","author":"Flach","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201816_bib25","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016428","article-title":"Sources of DNA double-strand breaks and models of recombinational DNA repair","volume":"6","author":"Mehta","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.omta.2026.201816_bib26","first-page":"2316","article-title":"Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci in mice","volume":"141","author":"Calabria","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201816_bib27","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.ymthe.2022.06.004","article-title":"Evaluating the state of the science for adeno-associated virus integration: An integrated perspective","volume":"30","author":"Sabatino","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201816_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf2444","article-title":"Development of beta-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease","volume":"13","author":"Lattanzi","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omta.2026.201816_bib29","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/sctm.20-0520","article-title":"Persistence of CRISPR\/Cas9 gene edited hematopoietic stem cells following transplantation: A systematic review and meta-analysis of preclinical studies","volume":"10","author":"Maganti","year":"2021","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.omta.2026.201816_bib30","series-title":"In the EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies","author":"Carreras","year":"2019"},{"key":"10.1016\/j.omta.2026.201816_bib31","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/sj.bmt.1701748","article-title":"Using at least 5x10(6)\/kg CD34+ cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation","volume":"23","author":"Scheid","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.omta.2026.201816_bib32","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/s41409-019-0573-6","article-title":"Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy","volume":"54","author":"Tucci","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.omta.2026.201816_bib33","doi-asserted-by":"crossref","first-page":"21267","DOI":"10.1073\/pnas.2001367117","article-title":"Efficient and nontoxic biomolecule delivery to primary human hematopoietic stem cells using nanostraws","volume":"117","author":"Schmiderer","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201816_bib34","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood.2022019333","article-title":"Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells","volume":"142","author":"Vavassori","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201816_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/crispr.2021.0120","article-title":"ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected","volume":"5","author":"Boutin","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.omta.2026.201816_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1339189","article-title":"Beyond the promise: evaluating and mitigating off-target effects in CRISPR gene editing for safer therapeutics","volume":"11","author":"Lopes","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.omta.2026.201816_bib37","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ymthe.2023.02.011","article-title":"Comparative analysis of CRISPR off-target discovery tools following ex vivo editing of CD34(+) hematopoietic stem and progenitor cells","volume":"31","author":"Cromer","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201816_bib38","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.3390\/cimb46080485","article-title":"Regulatory Assessment of Casgevy for the Treatment of Transfusion-Dependent beta-Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive Crises","volume":"46","author":"Kerwash","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.omta.2026.201816_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41588-022-01257-y","article-title":"Human genetic diversity alters off-target outcomes of therapeutic gene editing","volume":"55","author":"Cancellieri","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omta.2026.201816_bib40","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm.4377","article-title":"Implications of human genetic variation in CRISPR-based therapeutic genome editing","volume":"23","author":"Scott","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201816_bib41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.copbio.2018.07.005","article-title":"The influence of eukaryotic chromatin state on CRISPR-Cas9 editing efficiencies","volume":"55","author":"Verkuijl","year":"2019","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.omta.2026.201816_bib42","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3390\/genes11121501","article-title":"Genome-Wide Analysis of Off-Target CRISPR\/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones","volume":"11","author":"Smith","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.omta.2026.201816_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.stem.2024.10.013","article-title":"Post-transplant G-CSF impedes engraftment of gene-edited human hematopoietic stem cells by exacerbating p53-mediated DNA damage response","volume":"32","author":"Araki","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omta.2026.201816_bib44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt Removes Adapter Sequences From High-Throughput Sequencing Reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J."},{"key":"10.1016\/j.omta.2026.201816_bib45","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201816_bib46","first-page":"726","article-title":"Pheatmap: pretty heatmaps","volume":"1","author":"Kolde","year":"2019","journal-title":"R package version"},{"key":"10.1016\/j.omta.2026.201816_bib47","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/s41591-021-01389-4","article-title":"Retrieval of vector integration sites from cell-free DNA","volume":"27","author":"Cesana","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201816_bib48","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa2106596","article-title":"Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome","volume":"385","author":"Gentner","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2026.201816_bib49","article-title":"RAAVioli: A comprehensive approach to characterizing AAV vector integrations and rearrangements","volume":"34","author":"Carlo Cipriani","year":"2025","journal-title":"Mol Ther Adv."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:14:46Z","timestamp":1789053286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26001515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3117387X26001515"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201816","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-depth characterization of stem cell potency and genotoxicity for clinical-scale ex vivo CRISPR-Cas9 gene editing","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201816"}}